117 / 132
117
Food and Drug Administration
ڝ
ɓ
102
ϋᖹɽԫ
ߏ
ࣛ
ග
ɽԫ
ߏ
ࠅ
1
˜
11
˚
ࡌ
͍ਗ
ي
͜ᖹಞवᅺୋ
3
ૢ
ɓeᄣ
ࠈ
ɔ。ମ́。इᆀ९
Acetylisovaleryltylosin
e
Cefquinome
eശ
ɢอ
Cephalexin
eಣ
ۃ
ΐଖቐ
Cloprostenol
ʘಞव࢙ඎ
ɚeᄣ
ࠈࡌ
ᒄ๘ଋ
Cyromazine
e
๘ݯ
ഽ
Flumequine
e
ז
ᔜᖯ
Lasalocid
eइ९
Tylosin
ʘಞव࢙ඎ
ࡌ
͍ಞव༵ᖹτΌ࢙ඎᅺୋ
3
ૢʘ
ڌڝ
ɓjᄣ
ࠈࡌ
ԭ๘ഃ
5
၇༵ᖹί
23
၇Ъ
ي
āᗳ
йʘಞव༵ᖹτΌ࢙ඎ
1
˜
16
˚
ᐼ୕˿ʮ̺
ࡌ
͍ᖹԫ
ج
ୋ
41
ૢૢ˖d
މ
ᖹ
ي
Ⴁிʈุ˥ၾᑗґ༊᜕ۜሯd࿁ᑗґ
༊᜕ɛʑʿอጳᖹ
߅ي
ҦʘӺ೯࢝ᗫԫ֝Ъ
ࡌ
͍
2
˜
5
˚
ʮѓ
ࡌ
͍ੰۜʘҷഛ৶ሯଯᕦ൙П˙
ج
dΤ၈Ԩ
ࡌ
͍
މ
ੰۜʘ৶ሯ
ڭ
̌ࣖ൙П˙
ج
2
˜
7
˚
102
ϋᐏБ݁৫પਗй˴
ݴ
ʷ
ږ
ᙚᆤྠᆤ
3
˜
12
˚ ˸
FDA
ᖹοୋ
1011411038
Ռѓlz
ݟ
᜕೮া͜ᖹۜᑗґ༊᜕జѓ
GMP
ྼή
ݟ
ࣨࡡ
ۆ
3
˜
13
˚
೯̺
ࡌ
͍ਗ
ي
͜ᖹಞवᅺୋ
3
ૢ
ɓeᄣ
ࠈ
Ԏ˼
ߕ
Ӎؒ
(Betamethasone)
ίळᗳʘЄЂeӿeഥeইʿԪഃʞධಞव
࢙ඎ
ɚe
ࠈࡌ
ݯ
ʷ͠ਿ୭૫ͤሯቐ
Dexamethasone
ίळʿອᗳʘЄЂeӿeഥ
ʿইdळᗳʘԪഃɘධಞव࢙ඎ
ɧeᄣ
ࠈ
٭
ߛ
Febantel
e
Fenbendazole
ʿ
Oxfendazole
ί৵ʘЄЂeӿeഥe
ইdʿʆϺԪഃʞධಞव࢙ඎ
ࠈ
֛ࠥЭۜʕεᐑ
࠰ٹ
ૄ၁૫ʷΥ
ي
ўඎʘЪุܸˏ
3
˜
14
˚
೯̺
ࡌ
͍ಞव༵ᖹτΌ࢙ඎᅺୋ
3
ૢ
ɓeᄣ
ࠈࡌ
ୋ๘ྐྵഃ
6
၇༵ᖹί
16
၇Ъ
ي
ᗳйʘಞव༵ᖹτΌ࢙ඎi
ࠈࡌ
༵ᖹୋ๘ྐྵί
ࣨ
؈
ᗳʘЪ
ي
ᗳйΤ၈dાՉಞव༵ᖹτΌ࢙ඎʘરৰЪ
ࡌ ي
͍ૢ˖ୋ
3
ૢ¡
ɚeᄣ
ࠈ
ලቒࣱʃᆉ
؈
ᗳʿዔᝃࣨ
؈
ᗳf
ࡌ
͍ૢ˖ୋ
6
ૢ
3
˜
14
˚
ʮѓᔼᐕኜҿਖ਼ࣩፔ༔Ⴞኬ
ࠅ
ᓃ
͉
ࠅ
ᓃ
ڷ
ৣΥ͉
102
ϋ
ܓ
੶ʷᔼᐕኜҿ
ج
ፔ༔Ⴞኬਕdп͛Ҧପุ೯࢝dԨપ
ਗҢੂБᔼᐕኜҿᑗґ༊᜕ঐɢʘ݁ഄͦᅺdतᓒɽᔼҿਖ਼ࣩፔ༔Ⴞኬᇍఖ
4
˜
9
˚
೯̺
ࡌ
͍ۜኜՈ࢙ኜ̍ༀሊ͛ᅺୋ
5
ૢeୋ
6
ૢeୋ
7
ૢdՉ
ࡌ
͍
ࠅ
ᓃνɨj
ɓeᄣΐᏃ̼Յ̲ଧʔԴ͜ўᕐₒ
A
ʘ෧ᇭҿሯ֛f
ࡌ
͍ૢ˖ୋ
5
ૢ
ɚeмৰၳ၁ა◐
-
̲ଧʘ֛dмৰၳ߽ ዓইeၳ⺀ ዓইഃҿሯ๓̈༊᜕ʕϞᗫ
ᕐₒ
A
ʘࠢඎ֛dၳ߽ ዓইʘ
ߵ
˖Τ၈ʚ
ࡌ
͍f
ࡌ
͍ૢ˖ୋ
6
ૢ
ɧe͉ϣϞᗫᏃ̼Յ̲ଧᕐₒ
A
ʘ֛dІ
102
ϋ
9
˜
1
˚݄Б
(
˸ପପۜʘႡி˚ಂʿආ
ɹପۜʘᕎಥ˚
މ
dШ̹ࠦ
ݴ
ஷପۜʘ၍ՓdІ
103
ϋ
3
˜
1
˚݄Бf
ࡌ
͍ૢ
˖ୋ
7
ૢ
4
˜
10
˚
ʮѓ
ࡌ
͍ۜ̋
ي
Դ͜ᇍఖʿࠢඎࣸᅺୋ
3
ૢʘ
ڌڝ
ɚd
ࡌ
͍ሜբኒᓠᓝა
ඒʘࣸᅺ
4
˜
11
˚ ʮѓྼ݄፩ɝۜʿᗫପۜ༟ৃཫ͡జЪุҏ
4
˜
17
˚ ʮѓಔ
ي
ᖹอᖹ
ݟ
᜕೮াᄲ
ݟ
ਿ
4
˜
18
˚
ʮѓ
ࡌ
͍၍Փᖹۜʱॴʿۜධdᄣΐ˼ᄝ˼ᘨ
Tapentadol
މ
ୋɚॴ၍Փᖹۜʿ௦ቑ
ᖹۜd
JWH-122
ʿ
AM-2201
މ
ୋɧॴ၍Փᖹۜ